Pfizer’s Talzenna Takes On Top Dog Lynparza In Prostate Cancer

 
• By Alaric DeArment
  
Pfizer announced positive topline results from the TALAPRO-2 trial in mCRPC • Source: Shutterstock

More from Clinical Trials

More from R&D